Stem Cells for Retinal Disease Roger F. Steinert, MDRoger F. Steinert, MD Irving H. Leopold Professor and ChairIrving H. Leopold Professor and Chair Professor.

Slides:



Advertisements
Similar presentations
Who are we? Initiated by persons suffering from retinal diseases, our Association was founded in December of We associate persons suffering from:
Advertisements

Research Perspectives and the Promise of Clinical Trials for Treatment of RP and Allied Diseases: ohenetihool L Gerald J. Chader, Ph.D., M.D.hc Doheny.
UCL Institute of Ophthalmology Department of Genetics
0 0 Photobiomodulation The Healing Power of Light Janis T. Eells, Ph.D. Wisconsin Distinguished Professor.
Stem Cells Leah Yang.
Macular Degeneration Amanda Thompson Mrs. Jensen Block 3.
Eye Disease Simulations Lien Bui Period 2. Normal Vision Normal vision is also known as “20/20” meaning that a person can see details from 20 feet away.
Current Issues Sensory substitution: Visual cortex in the blind (Current Directions 6, 2005)
Application of MEMS in Optobionics: Retinal Implant
SAMIR AL-MANSOURI, MD. e.g. - cataract - glaucoma - macular degeneration - diabetic retinopathy Chronic = slowly progressive visual loss Major causes:
Stem Cells and Regenerative Medicine
When a person has lost their sight to a damaged retina there is now technology that allows them to see again. By means of a chip which sends electrical.
By: Caleb Earley.  The cone cells are located in the human eye  More specifically found in the retina of the human eye.
Age-Related Macular Degeneration Treatment Robert Thottam.
Examples of Aging Simulation Developed in Japan, 2005 Developed at Duke, article from JAMA, 1989.
Nerve Cell Regeneration Heather Wilson and Alicia DiCola.
In Vivo Snapshot Hyper Spectral Image Analysis of Age-Related Macular Degeneration (AMD) The 32 nd Annual International Conference of the IEEE EMBS August.
Eye Disease and Their View. – Color-Blind – Macular degeneration – Cataracts – Diabetic retinopathy – Glaucoma – Presbyopia-refractive error – Diplopia.
1 Testing sensory visual function. 2 types: 1) psychophysical tests 2) electrophysical tests.
Congress Highlights: Progress in Retinal Degeneration Research From Scientific Darkness to the Light of Clinical Trials ohenetihool L Gerald J. Chader,
Neural Progenitor Cells as Replacement Therapy for Diseased and Aging Brains. R.G. Jarman, E. Alveraz, C.R. Freed; Division of Clinical Pharmacology, Dept.
AGED-RELATED MACULAR DEGENERATION. (AMD) BY: Basiru Lee Leigh Mentor: Dr. Lee Angioletti Angioletti Retina Associates.
Mobility Program Information on eye diseases and disorders was obtained at the St. Lukes Eye Clinic Website
GRADUAL PAINLESS DETERIORATION OF VISION MAJ SADIA HUMAYUN CLASSIFIED EYE SPECIALIST AFIO.
Stem Cell Research By: Jarrit Locke. The Benefits of Stem Cells  Curing diseases  Repairing damaged organs  Healing burns and scars  Advancements.
Visuals: Anastasia Veloudos Facts: Dahlia Glanton Speaker: Madison Williams NIGHT AND COLOR BLINDNESS.
MRC Mouse Network Jan 2012 Mouse eyes and vision research consortium Prof Marcela Votruba PhD FRCOphth Prof Ian Jackson PhD.
General Anatomy of the Eye & Degenerative Diseases of Human Retina
ARTIFICIAL EYE By U.Sandhya Rani 08A91A04A7.
 Stem Cells. Definition  The capacity of cells to divide and differentiate along different pathways is necessary in embryonic development. It also makes.
Present and Future Treatments for Retinal Degenerative Diseases: An Overview Gerald J. Chader Doheny Retina Institute USC Medical School Los Angeles, CA.
RETINOPATHY OF PREMATURITY. What is Retinopathy of Prematurity (ROP)? b Disease of the retina in premature infants b Usually occurs in 1.5 kg or less.
2) Vision The Special Senses 13 th edition Chapter 17 Pages th edition Chapter 17 Pages
Visual Impairment. Factors Affecting Visual Function and Their Treatment Visual Acuity - ability to see "detail" –Measured using testing distance/letter.
Bionic Eyes Robert Blease. Target Current designs are made for patients with degenerative eye disorders. The most common disorder currently treatable.
Retinal and Cortical Implants. Stat 19 SEM Talk 4. The brain is a network of nerve cell, neurons. The neurons communicate by electrical and.
The Eye & The Action (Receptor) Potential Packet #20 Chapter #49.
Retinitis Pigmentosa Paulette Frank, Amy Hayes, Monica Johnson, and Michelle Parker.
Volume 2, Issue 1, (January 2013)
Myopia (Nearsighted) Eyeball too long Distant objects focused in front of retina Image striking retina is blurred Correction: Concave lens or laser surgery.
Gene Therapy in Retinitis Pigmentosa (RP) Henry J Kaplan, MD Evans Professor of Ophthalmology Chair, Department of Ophthalmology & Visual Sciences Director,
Fundamentals of Sensation and Perception DISORDERS OF VISION ERIK CHEVRIER NOVEMBER 18, 2015.
Two-step Reactivation of Dormant Cones in Retinitis Pigmentosa
صدق الله العظيم الاسراء اية 58 By Dr. Abdel Aziz M. Hussein Lecturer of Physiology Member of American Society of Physiology.
CONTENTS INTRODUCTION WHO IS ELIGIBLE ? DEVICE WORKING
Retinitis Pigmentosa (RP)
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
Usher Syndrome By Andy Beer. What is Usher Syndrome Usher Syndrome is a genetic disease on witch you lose the ability to hear and see. The major symptoms.
ARTIFICIAL VISION –A BIONIC EYE. INTRODUCTION ‘Bionoic eye’ also called a ‘BioElecronic eye’, is the electronic device that replaces functionality of.
Nathan Lighthizer, O.D., F.A.A.O Assistant Professor, NSUOCO Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic COPE Approved: COPE # PD.
ARTIFICIAL EYE
Usher syndrome By Andy Beer.
Light micrographs of a normal human retina (left), a retina with retinitis pigmentosa (center), and a retina with end-stage retinitis pigmentosa (right).
Arch Ophthalmol. 2000;118(6): doi: /archopht Figure Legend:
INTRAVITREAL INJECTION OF
Stem cells and nerve cell renewal in glaucoma
Using stem cells to understand blinding eye diseases
COACHES & DIRECTORS TRAINING
From: Retinal Stem Cells Transplanted into Models of Late Stages of Retinitis Pigmentosa Preferentially Adopt a Glial or a Retinal Ganglion Cell Fate Invest.
General Anatomy of the Eye & Degenerative Diseases of Human Retina
The Eye as a Camera Michael A. Sandberg, Ph.D.
Retinitis Pigmentosa Owen Ferrara.
THE EYES AND VISION.
Loai Alzghoul
Vision Science: Can Rhodopsin Cure Blindness?
Vision Science: Can Rhodopsin Cure Blindness?
Theodore G. Drivas, Jean Bennett  Neuron 
Neural Regeneration and Cell Replacement: A View from the Eye
Depicting brighter possibilities for treating blindness
Fig. 1 Relevance of therapies for treating retinal degeneration and stage of disease. Relevance of therapies for treating retinal degeneration and stage.
Presentation transcript:

Stem Cells for Retinal Disease Roger F. Steinert, MDRoger F. Steinert, MD Irving H. Leopold Professor and ChairIrving H. Leopold Professor and Chair Professor of Biomedical EngineeringProfessor of Biomedical Engineering Director, Gavin Herbert Eye InstituteDirector, Gavin Herbert Eye Institute University of California, IrvineUniversity of California, Irvine Relevant Disclosures: None

Acknowledgment of UC Irvine Research Leader Henry J. Klassen, MD, PhD Associate Professor Director, Stem Cell and Retinal Regeneration Program Gavin Herbert Eye Institute University of California, Irvine

Further Acknowledgements UC Irvine -Jing Yang –Gu Ping –Joann You –Jinmei Wang –Tianran Song –Steven Menges Univ. of Missouri-Columbia –Randal Prather –Kristina Narfstrom Duke Univ., NCSU - Fulton Wong -Robert Petters Panum Institute, Copenhagen –Morten la Cour –Jens Kiilgaard –Maria Voss University of Lund –Karin Warfvinge –Ulrica Englund Klassen Lab: UCI Harvard (SERI) –Michael Young –Caihui Jiang

Retinitis Pigmentosa (RP) What the doctor seesWhat the patient sees Retinal Degenerations: Symptoms Differ Age-Related Macular Degeneration (AMD)

Retinal Degenerations share a problem In both cases: loss of photoreceptors (rods/cones)

How to replace photoreceptors? Retinal Progenitor Cells (RPCs)  From the developing neural retina  RPCs are immature cells  Like stem cells, but self-renewal ends automatically  Perhaps why the retina loses the ability to regenerate?  Can be transplanted  Migrate  Integrate  Differentiate into retinal cells RPCs are the cells that make the retina, so they know what to do! RPCs in the lab

To first study the effect in mice need to make RPCs from green fluorescent mice Molecular analysis   RPCs

Transplant to retina of blind mice Now look for the green fluorescent cells: These cells are from the transplant, yet look like normal retinal cells that have integrated into the right position. Rod photoreceptors Bipolar cells

GFP Rhodopsin Recoverin RPC transplantation has also been done in blind transgenic pigs, using cells from green fluorescent pigs New photoreceptors Green fluorescent pigs

Human RPCs have now been grown in the lab, using similar techniques Vimentin SOX2  Human RPCs The cells are analyzed using molecular stem cell markers

11 Human RPCs make new photoreceptors when transplanted to the retina of blind rodents From Jiang et al. Next step is to get FDA approval to test human RPCs in patients with retinal degenerative disease

Targeted Diseases  Retinal degenerations  Retinitis Pigmentosa (RP) and other dystrophies  Age-Related Macular Degeneration (AMD)  Retinal detachment  Optic nerve degenerations  Glaucoma and other optic neuropathies

Thank You!!